Pre-listing capital base
The pre-listing balance sheet expanded with project investment and funding; these are company records, not public-market trading data.
Ballymore’s five-year financial story is the funding of exploration and possible mine redevelopment, not established gold production. The Dittmer royalty financing lifted cash in FY2024; spending then reduced liquidity while finance expense widened the accounting loss.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
Includes committed Dittmer cash.
Statutory, not total cash expenditure.
Investing cash outflow.
As disclosed by directors.
The September 2021 ASX admission followed an A$7m gross IPO. Later funding combined new shares with a Taurus royalty agreement, so comparing financing cash with equity alone understates the obligation created.
By June 2025 part of the remaining cash was committed to Dittmer. Directors disclosed a material going-concern uncertainty even while retaining the going-concern basis after a subsequent placement.
The pre-listing balance sheet expanded with project investment and funding; these are company records, not public-market trading data.
The August 2021 IPO raised A$7m gross and listing followed in September.
Stage 3 underground drilling was completed and mine-development studies advanced; a restart was not treated as achieved production.
Taurus provided US$5m, recorded as A$7.576m in the funding receipt, against Dittmer gold-sale royalties.
Directors identified material going-concern uncertainty. A later A$4.518m placement is a subsequent event, not June cash.
Assets and equity increased from the pre-listing base, but cash did not rise steadily. The latest total cash balance includes project commitments and should not be presented as wholly unallocated liquidity.
A$ million
AI-generated presentation · values from Financial position across five years; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Financial position across five years; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash and equivalents | 0.224 | 2.539 | 1.475 | 7.939 | 2.302 |
| Total assets | 3.985 | 10.370 | 13.185 | 23.613 | 22.977 |
| Total equity | 3.713 | 9.999 | 12.717 | 15.018 | 12.693 |
FY2021 predates the September 2021 listing but is a company financial period, not an ASX trading-price history. Assets are accounting carrying values.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2024 | FY2025 |
|---|---|---|
| Total cash | 7.939 | 2.302 |
| Cash committed to Dittmer | 5.629 | 1.659 |
| Total liabilities | 8.595 | 10.284 |
| Current liabilities | 0.776 | 0.951 |
Committed cash is included in, not additional to, total cash. Total liabilities include the royalty funding obligation; this table does not equate all liabilities with bank debt.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The main project cash spend sits in investing activities. FY2024 royalty funding helped finance development, while FY2025 reported no new net financing inflow. Announced subsequent funding is kept out of the historical statement.
A$ million
AI-generated presentation · values from Loss and cash movements; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Loss and cash movements; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Statutory net loss | (0.569) | (0.734) | (0.878) | (1.898) | (2.325) |
| Operating cash flow | (0.286) | (0.668) | (0.659) | (1.024) | (0.723) |
| Investing cash flow | (3.384) | (3.597) | (3.873) | (3.551) | (4.914) |
| Financing cash flow | 3.483 | 6.580 | 3.467 | 11.040 | 0.000 |
FY2025 financing is reported nil, not an unresolved blank. FY2024 financing includes royalty funding and is not all equity capital. Exploration spending is investing cash, outside operating cash burn.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The royalty financial liability is measured at amortised cost using a 17% effective interest rate. FY2025 interest expense of A$1.487m therefore belongs in the earnings explanation; it is not a second A$1.487m receipt of funding or current gold sales.
A$ million
AI-generated presentation · values from Recent funding and investment components; no missing values plotted as zero.
A$ million
| Metric | FY2024 | FY2025 |
|---|---|---|
| Gross share proceeds | 3.616 | 0.000 |
| Royalty funding receipts | 7.576 | 0.000 |
| Exploration cash payments | (3.449) | (4.811) |
| Plant and equipment cash payments | (0.103) | (0.103) |
Royalty funding is a financing receipt with a continuing obligation, not gold sales revenue. Post-year-end placement proceeds are not included.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.